Glioma

As a glioma grows, it presses on surrounding healthy parts of the brain, affecting their function. As such, the symptoms of a pediatric glioma depend heavily on the tumor's size and where in the brain it is located. Some of the most common symptoms of a pediatric glioma include:

• headache
• severe or frequent vomiting
• vision problems such as double vision, blurry vision, or loss of vision
• difficulty walking or balancing
• seizures
• weight gain or loss
• premature puberty
• clumsiness
• confusion
• sleepiness

To diagnose a pediatric glioma, your doctor will take your child's medical history and carry out both physical and neurological exams. Your doctor may also order a variety of tests, including:

• magnetic resonance imaging (MRI)
• biopsy or tissue sample
• electroencephalogram (EEG)
• lumbar puncture

Our treatment approach for pediatric gliomas is personalized for each patient depending on several factors, including the tumor's type, stage, and location. Some therapies will treat the tumor, while others are intended to address complications of the disease or side effects of the treatment.

In addition, our clinicians may offer access to targeted treatments based on the molecular profile of your child's tumor. Some of the options your doctor may discuss include surgery, chemotherapy, or radiation therapy.

Children and adolescents with glioma are treated at Dana-Farber/Boston Children’s Cancer and Blood Disorder Center through the Brain Tumor Center's Glioma Program, one of the largest and most experienced pediatric glioma programs in the world.

Our glioma specialists — a team of neuro-oncologists, surgeons, pathologists, and radiation oncologists — focus solely on the care of children diagnosed with gliomas. The Glioma Program also offers families the chance to have their child's tumor molecularly profiled (as long as a biopsy can be taken), which may help identify opportunities for targeted treatment.

Research is a top priority at Dana-Farber/Boston Children's, and our physicians work continuously to translate laboratory findings into clinical therapies and find ways to improve survival while reducing the toxicity and long-term impact of treatment.

It’s possible that your child will be eligible to participate in one of the Glioma Program’s current clinical trials. In addition to launching our own clinical trials, we also offer trials available through collaborative groups such as the Children's Oncology Group (COG) and the Pacific Pediatric Neuro-Oncology Consortium (PNOC).